What does Lexicon Pharmaceuticals, Inc. do?
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and…
What is Lexicon Pharmaceuticals, Inc.'s P/E and P/B ratio?
Lexicon Pharmaceuticals, Inc. has a P/E ratio of -9.3 and a P/B ratio of 3.80.
What is Lexicon Pharmaceuticals, Inc.'s debt-to-equity ratio?
Lexicon Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.34.
How much does Lexicon Pharmaceuticals, Inc. owe compared with what it owns?
Lexicon Pharmaceuticals, Inc. owes $0.30 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Lexicon Pharmaceuticals, Inc.'s Positivity rank?
Lexicon Pharmaceuticals, Inc. is ranked #4,783 of 6,775 companies globally and #2,469 of 4,000 in United States on PositoAI, with a Positivity Score of 19,017.
Does Lexicon Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Lexicon Pharmaceuticals, Inc..
Where can I read the latest news about Lexicon Pharmaceuticals, Inc.?
Recent headlines about Lexicon Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Lexicon Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Lexicon Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.